Pharmaceutical research in 2026 is undergoing a structural transformation. Traditional small-molecule drug discovery, once centered on single-target mechanisms, is increasingly being replaced by multi-pathway biological models. Within this shift, peptide-based compounds have become a central focus in metabolic, endocrine, and regenerative research pipelines. Modern drug development is no longer limited to isolated receptor interaction. Instead,[ Read more…]